NBY Financial Facts
Basic and diluted (in Dollars per share): -0.34Operating income (loss): -2.01M
See Full Income Statement
Property and equipment, net: 282K
Deferred revenues - non-current: 1.91M
See Full Balance Sheet
NovaBay Pharma (NBY) Earnings
|
Expand Research on NBY
| Next EPS Date | N/A | EPS Growth Rate | -270.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -71.0% | Revenue Growth Rate | -14.6% *Last Qtr. |
| Average % Move 1-Wk after EPS | +18.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/9/23 | Q323 | -$0.37 | -$0.41 | +$0.04 | $3.27M | $3.54M | N/A |  | | Details | |
| 11/14/22 | Q322 | -$0.10 | -$0.03 | -$0.07 | $3.83M | $3.75M | N/A | | | Details | |
| 8/11/22 | Q222 | -$0.04 | -$0.04 | $0.00 | $2.13M | $3.5M | N/A | | | Details | |
| 5/11/23 | Q122 | -$0.85 | -$0.53 | -$0.32 | $3.12M | $5.45M | N/A | | | Details | |
| 3/29/22 |  |
Q421 | -$0.02 | -$0.05 | +$0.03 | $2.6M | $3.34M | N/A | | | Details |
| 8/12/21 | |
Q221 | -$0.04 | -$0.04 | $0.00 | $2.1M | $2.01M | N/A | | | Details |
5/6/21  |
|
Q121 | N/A | -$0.04 | N/A | N/A | $2.34M | N/A | N/A | N/A | |
| 3/25/21 | |
Q420 | -$0.04 | -$0.04 | $0.00 | $1.9M | $2.48M | N/A | | | Details |
